The purpose of this study is to assess the sensation of ocular dry eye symptom after an intravitreal injection of anti-VEGF.
The recrutement of the patient is done during the inclusion of the patient by the nurses of the ophtalmological service of clermont-ferrand and confirm by an ophtalmologist of the service. A mesure of the OSDI is done before the injection, then at 1 day, on week by a phone call. Each of this mesures are done for the 2 other injections. Before each of this injection, a clinical mesure is done by a lacrydiag: the atrophy of the meibomian glands, the non-invasive break-up time, interferometry, the heigh of the tear meniscum.
Study Type
OBSERVATIONAL
Enrollment
50
CHU de Clermont-Ferrand
Clermont-Ferrand, France
RECRUITINGOSDI
Ocular Surface Disease Index: 12 questions treating of either the sensation, the visual impact and the environemental impact of the dry eye disease
Time frame: before the injection and at 1 day
OSDI
Ocular Surface Disease Index: 12 questions treating of either the sensation, the visual impact and the environemental impact of the dry eye disease
Time frame: before the injection and at 1 week
HM
MH: hauteur méniscal : high of meniscal tear film
Time frame: before each injection
AM
Atrophie meibomienne: meibomian atrophy
Time frame: before each injection
NIBUT 1
First Non Invasive Break-Up Time: time when the tear film lose is regularity regardless of is location
Time frame: before each injection
NIBUT 2
Average Non Invasive Break-Up Time : average time when the tear film lose is regularity for each location
Time frame: before each injection
Interferometry
Interferometry: High of the lipid film of the tear
Time frame: before each injection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.